(Q39776026)

14 September 2017

title

The pharmaceuticalisation of society? A framework for analysis (English)

1 reference

14 September 2017

Simon J Williams

1

1 reference

14 September 2017

Paul Martin

series ordinal

2

1 reference

14 September 2017

Jonathan Gabe

series ordinal

3

1 reference

14 September 2017

publication date

4 March 2011

1 reference

Sociology of Health and Illness

14 September 2017

published in

1 reference

14 September 2017

volume

33

1 reference

14 September 2017

issue

5

1 reference

14 September 2017

page(s)

710-725

1 reference

On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and Lexchin

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

Embodied health movements: new approaches to social movements in health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

Globalization and the pharmaceutical industry revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

'A pill for every ill': explaining the expansion in medicine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

The shifting engines of medicalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

Estimating the costs of medicalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

The 'expert patient': empowerment or medical dominance? The case of weight loss, pharmaceutical drugs and the Internet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

Pro-anorexia, weight-loss drugs and the internet: an "anti-recovery" explanatory model of anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

Adjusting Europe's drug regulation to public health needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

Towards responsible use of cognitive-enhancing drugs by the healthy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

The mundane realities of the everyday lay use of the internet for health, and their consequences for media convergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

The myth of the biotech revolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

Chronic illness, expert patients and care transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

Integrating pharmacogenetics into society: in search of a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

The myth of the biotech revolution: An assessment of technological, clinical and organisational change

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-9566.2011.01320.X

10.1111/J.1467-9566.2011.01320.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference